ConductScience.org, home

Paper40920573

Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.

Bruno T and 23 others. Blood, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy. Papers, record 40920573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40920573

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.
PubMed
Journal
Blood
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-10-28
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bruno TTizianahttps://orcid.org/0000-0003-0352-4523
2Cappelletto MCMaria Chiarahttps://orcid.org/0009-0006-9040-005X
3Cortile CCleliahttps://orcid.org/0000-0001-9017-6373
4Di Giovenale SStefanohttps://orcid.org/0000-0002-2484-7308
5Amadio BBruno
6De Nicola FFrancesca
7Falcone IItaliahttps://orcid.org/0000-0003-2796-0792
8Giuliani SStefanohttps://orcid.org/0009-0008-9905-7870
9Palermo BBelindahttps://orcid.org/0000-0001-6293-0113
10Catena VValeria
11Ciuffreda LLudovicahttps://orcid.org/0000-0002-7964-7119
12Cerruti FFulvia
13Cascio PPaolo
14Merola RRoberta
15Masi SSerena
16De Pascale VValentina
17Annibali OOmbrettahttps://orcid.org/0000-0002-3095-5313
18Ferraro SSilvia
19Gumenyuk SSvitlana
20Pisani FFrancescohttps://orcid.org/0000-0002-6853-5605

Source PubMed

See all 24 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple MyelomaMajor topic
Nuclear Respiratory Factor 1Major topic
Proteasome InhibitorsMajor topic
BortezomibMajor topic
Humans
Animals
Mice
Cell Survival
Cell Line, Tumor
Xenograft Model Antitumor Assays
Enhancer Elements, Genetic
Proteasome Endopeptidase Complex
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in41379498Enhancing the targeting of the undruggable.https://conductscience.org/library/papers/41379498

Source PubMed

Download CSV of comments and corrections

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119076454Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator.Ann N Y Acad Sci2008https://conductscience.org/library/papers/19076454PubMed
225838343Pathogenesis beyond the cancer clone(s) in multiple myeloma.Blood2015https://conductscience.org/library/papers/25838343PubMed
318568025IRF4 addiction in multiple myeloma.Nature2008https://conductscience.org/library/papers/18568025PubMed
426992692Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.J Exp Clin Cancer Res2016https://conductscience.org/library/papers/26992692PubMed
516728703The molecular classification of multiple myeloma.Blood2006https://conductscience.org/library/papers/16728703PubMed
620485488A large fraction of extragenic RNA pol II transcription sites overlap enhancers.PLoS Biol2010https://conductscience.org/library/papers/20485488PubMed
739160255Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.Nat Genet2024https://conductscience.org/library/papers/39160255PubMed
824097267Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.Nat Methods2013https://conductscience.org/library/papers/24097267PubMed
917308121Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.Cancer Res2007https://conductscience.org/library/papers/17308121PubMed
1038514625Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma.Nat Commun2024https://conductscience.org/library/papers/38514625PubMed
1132848148ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation.Nat Commun2020https://conductscience.org/library/papers/32848148PubMed
1233007258A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.Cancer Cell2020https://conductscience.org/library/papers/33007258PubMed
1323729400Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma.Mol Cancer Ther2013https://conductscience.org/library/papers/23729400PubMed
1419451168Fast and accurate short read alignment with Burrows-Wheeler transform.Bioinformatics2009https://conductscience.org/library/papers/19451168PubMed
1530245231Drug resistance in multiple myeloma.Cancer Treat Rev2018https://conductscience.org/library/papers/30245231PubMed
1622645181Proteasome inhibitors in multiple myeloma: 10 years later.Blood2012https://conductscience.org/library/papers/22645181PubMed
1720639541BigWig and BigBed: enabling browsing of large distributed datasets.Bioinformatics2010https://conductscience.org/library/papers/20639541PubMed
1821441462Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.Blood2011https://conductscience.org/library/papers/21441462PubMed
198808631Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly.Cell1996https://conductscience.org/library/papers/8808631PubMed
208253388NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators.Genes Dev1993https://conductscience.org/library/papers/8253388PubMed

See all 70 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
41776655Challenges and advances in drug resistance and tolerance in cancer.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/41776655

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
NRF14899PubTator's text mininghttps://conductscience.org/library/genes/4899NCBI Gene
SDC16382PubTator's text mininghttps://conductscience.org/library/genes/6382NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40920573

GET https://conductscience.org/api/papers/v1/40920573/authors?page=2